Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: A review

Gordon C. Hunt, Douglas Orrick Faigel

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

EUS is a highly sensitive test for detecting small pancreatic masses and is accurate in determining vascular invasion of the portal venous system, a major determinant of resectability. Helical CT is an advance over standard CT in its ability to detect and stage pancreatic cancer and should be performed before EUS to rule out metastatic and obviously unresectable cancer. EUS should be performed when no unresectable disease is found or if a tumor is not visualized, although suspected. PET scanning may be a useful adjunct to detect occult metastatic disease, and MRI or angiography may be used to confirm vascular invasion in selected patients. EUS staging and FNA can be performed in a single procedure, unlike CT and CT-FNA, which require separate procedures. EUS-FNA should be considered in the majority of patients undergoing EUS to establish the diagnosis of cancer, determine histologic type, confirm lymph node histology, guide therapy, and assist with counseling of patients and referring physicians.

Original languageEnglish (US)
Pages (from-to)232-237
Number of pages6
JournalGastrointestinal Endoscopy
Volume55
Issue number2
DOIs
StatePublished - Feb 2002
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Endoscopic Ultrasound-Guided Fine Needle Aspiration
Blood Vessels
Portal System
Neoplasms
Aptitude
Spiral Computed Tomography
Magnetic Resonance Angiography
Counseling
Histology
Lymph Nodes
Physicians
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer : A review. / Hunt, Gordon C.; Faigel, Douglas Orrick.

In: Gastrointestinal Endoscopy, Vol. 55, No. 2, 02.2002, p. 232-237.

Research output: Contribution to journalArticle

@article{cfeef91ddc2443c0aef664b7fdec184e,
title = "Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: A review",
abstract = "EUS is a highly sensitive test for detecting small pancreatic masses and is accurate in determining vascular invasion of the portal venous system, a major determinant of resectability. Helical CT is an advance over standard CT in its ability to detect and stage pancreatic cancer and should be performed before EUS to rule out metastatic and obviously unresectable cancer. EUS should be performed when no unresectable disease is found or if a tumor is not visualized, although suspected. PET scanning may be a useful adjunct to detect occult metastatic disease, and MRI or angiography may be used to confirm vascular invasion in selected patients. EUS staging and FNA can be performed in a single procedure, unlike CT and CT-FNA, which require separate procedures. EUS-FNA should be considered in the majority of patients undergoing EUS to establish the diagnosis of cancer, determine histologic type, confirm lymph node histology, guide therapy, and assist with counseling of patients and referring physicians.",
author = "Hunt, {Gordon C.} and Faigel, {Douglas Orrick}",
year = "2002",
month = "2",
doi = "10.1067/mge.2002.121342",
language = "English (US)",
volume = "55",
pages = "232--237",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer

T2 - A review

AU - Hunt, Gordon C.

AU - Faigel, Douglas Orrick

PY - 2002/2

Y1 - 2002/2

N2 - EUS is a highly sensitive test for detecting small pancreatic masses and is accurate in determining vascular invasion of the portal venous system, a major determinant of resectability. Helical CT is an advance over standard CT in its ability to detect and stage pancreatic cancer and should be performed before EUS to rule out metastatic and obviously unresectable cancer. EUS should be performed when no unresectable disease is found or if a tumor is not visualized, although suspected. PET scanning may be a useful adjunct to detect occult metastatic disease, and MRI or angiography may be used to confirm vascular invasion in selected patients. EUS staging and FNA can be performed in a single procedure, unlike CT and CT-FNA, which require separate procedures. EUS-FNA should be considered in the majority of patients undergoing EUS to establish the diagnosis of cancer, determine histologic type, confirm lymph node histology, guide therapy, and assist with counseling of patients and referring physicians.

AB - EUS is a highly sensitive test for detecting small pancreatic masses and is accurate in determining vascular invasion of the portal venous system, a major determinant of resectability. Helical CT is an advance over standard CT in its ability to detect and stage pancreatic cancer and should be performed before EUS to rule out metastatic and obviously unresectable cancer. EUS should be performed when no unresectable disease is found or if a tumor is not visualized, although suspected. PET scanning may be a useful adjunct to detect occult metastatic disease, and MRI or angiography may be used to confirm vascular invasion in selected patients. EUS staging and FNA can be performed in a single procedure, unlike CT and CT-FNA, which require separate procedures. EUS-FNA should be considered in the majority of patients undergoing EUS to establish the diagnosis of cancer, determine histologic type, confirm lymph node histology, guide therapy, and assist with counseling of patients and referring physicians.

UR - http://www.scopus.com/inward/record.url?scp=0036484838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036484838&partnerID=8YFLogxK

U2 - 10.1067/mge.2002.121342

DO - 10.1067/mge.2002.121342

M3 - Article

C2 - 11818928

AN - SCOPUS:0036484838

VL - 55

SP - 232

EP - 237

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 2

ER -